PRN introduces the most advanced Macular Vitamin Benefits formulation based on study results in Advanced AMD Patients
PLYMOUTH MEETING, Pa., Sept. 3, 2013 /PRNewswire/ — Earlier this month, PRN Physician Recommended Nutriceuticals, a premier producer of condition-specific omega-3 products and macular vitamins, responded to the guidance from the long-term Age-Related Eye Disease Study 2 (AREDS-2) and launched a reformulation of the Macular Vitamin Benefits product. Chief Medical Officer, Michael B. Gross, MD, noted, “Based on the study results, a tremendous opportunity has arisen for Advanced Age-related Macular Degeneration (AMD) patients. PRN’s Macular Vitamin Benefits specifically meets the AREDS-2 recommendation, but it is also formulated with enhancements that reflect the years of proven clinical data in treatment of advanced AMD. As the most comprehensive product on the market, this now enables doctors to significantly impact the progression of the disease in their advanced AMD patients.”
PRN’s commitment to stay current and reformulate products in response to the ever-evolving body of evidence and in consultation with a panel of medical experts, led the company to create this advanced Macular Vitamin formulation. PRN’s Macular Vitamin Benefits aligns with the AREDS-2 study recommendations through the inclusion of lutein (10 mg), zeaxanthin (2 mg), and a minimum dose of zinc necessary to achieve therapeutic benefit (25mg). Additionally, the product maintains two critical enhancements: (1) The natural form of Vitamin E, and (2) A full B-Complex for neuroprotective effect. Similar to the product’s predecessor, the reformulated Macular Vitamin Benefits continues to exclude beta-carotene based on the studies showing a correlated risk between beta-carotene and lung cancer in smokers.
PRN’s Macular Vitamin Benefits is distributed exclusively through a physician’s recommendation, and for general macular health, Macular Vitamin Benefits is often coupled with PRN’s Eye Omega Advantage, a re-esterified triglyceride form omega-3 (EPA/DHA).
About PRN Physician Recommended Nutriceuticals
PRN is a leading developer of specialty omega-3 products and nutritional supplements. Developed by doctors and recommended by world-renowned medical thought leaders, PRN products are supported by a vast body of clinical evidence. Additionally, PRN product formulations and manufacturing practices are designed to ensure purity and to maximize the body’s absorption of the key ingredients like omega-3 (EPA/DHA), uniquely enabling patients to receive the optimal dose of these essential nutrients. PRN was recently acknowledged on the Inc. 500|5000 list of fastest growing privately held companies for the second consecutive year.
SOURCE PRN Physician Recommended Nutriceuticals